Tvardi Therapeutics Inc. (TVRD) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
40.23
2.86 (7.65%)
At close: Oct 03, 2025, 3:59 PM
40.55
0.80%
After-hours: Oct 03, 2025, 04:21 PM EDT

Tvardi Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Net Income
-506K -4.91M -7.68M -12.48M -20.02M -30.7M -4.35M -28.03M
Depreciation & Amortization
47K n/a n/a 73K 77K 42K 24K 521K
Stock-Based Compensation
-719K 1.43M n/a n/a n/a 3.35M 85K n/a
Other Working Capital
-460K -484K 1.85M -2.97M 2.38M 4.09M -1.52M 1.87M
Other Non-Cash Items
-10.13M 94K 5.43M 8.98M 5.36M 1.74M 13K 3.23M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
2.44M -1.31M -1.79M -10.56M 2.14M -4.88M -1.52M 4.63M
Operating Cash Flow
-8.87M -4.69M -4.04M -13.98M -12.44M -30.45M -5.75M -19.64M
Capital Expenditures
n/a n/a n/a n/a -210K -836K -2.05M -323K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-31.49M n/a n/a n/a 32.21M -32.21M -65M -22.85M
Sales Maturities Of Investments
11.05M n/a 5M 2.5M 15.5M 59M 36.85M 46.33M
Other Investing Acitivies
n/a n/a n/a n/a -32.21M n/a n/a n/a
Investing Cash Flow
-20.43M n/a 5M 2.5M 15.29M 25.95M -30.2M 23.16M
Debt Repayment
-1.01M 1.01M -1.61M -694K -610K -685K 36.47M n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
22.6M n/a n/a n/a -5K n/a n/a n/a
Financial Cash Flow
22.02M 1.01M -1.61M -694K -610K -685K 36.48M 1.12M
Net Cash Flow
-13.57M -3.69M -658K -10.68M 2.24M -5.19M -5.75M 4.63M
Free Cash Flow
-8.87M -4.69M -4.04M -13.98M -12.65M -31.29M -5.75M -19.97M